sorafenib has been researched along with vinpocetine in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (vinpocetine) | Trials (vinpocetine) | Recent Studies (post-2010) (vinpocetine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 6 | 0 | 5 |
| 6,520 | 730 | 5,251 | 652 | 62 | 212 |
| Protein | Taxonomy | sorafenib (IC50) | vinpocetine (IC50) |
|---|---|---|---|
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Homo sapiens (human) | 7.99 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.039 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Dong, SM; Li, YL; Liu, HQ; Liu, YH; Shao, JA; Zeng, LH; Zhang, C; Zhang, JK; Zhang, MM; Zhang, ZY; Zhu, HJ | 1 |
2 other study(ies) available for sorafenib and vinpocetine
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Enhanced anticancer activity by the combination of vinpocetine and sorafenib via PI3K/AKT/GSK-3β signaling axis in hepatocellular carcinoma cells.
Topics: Apoptosis; Autophagy; Cell Proliferation; Drug Therapy, Combination; Glycogen Synthase Kinase 3 beta; Hep G2 Cells; Humans; Phosphatidylinositol 3-Kinases; Signal Transduction; Sorafenib; Vinca Alkaloids | 2021 |